Renal Transplantation in the Era of Positive Hepatitis C Viremic Donors

Please join us for our next Pharmacy Resident Seminar presentation on Tuesday, November 23, 2021, presented by UIC College of Pharmacy PGY1 Pharmacy Practice Resident, Kaitlyn Legg, PharmD.

Type of Activity: Knowledge                             Target Audience: Pharmacists

Time: Tuesday, November 23, 2021,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2021-2022
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)
Meeting ID: 871 4292 0130
Passcode: 25699265

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Identify the risks and benefits of using hepatitis C virus (HCV) positive organs in renal transplantation
• Identify an appropriate drug regimen for the treatment of HCV in patients receiving HCV positive renal transplants
• Summarize the investigational medication practices being used in clinical trials for the treatment of HCV post renal transplant

Disclosure: The speaker, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose. Mentor, Dr. Muran has no relevant conflicts of interest. Mentor, Dr. Martin is on the speaker’s bureau/advisory board of Merck and Gilead. Dr. Martin is a stockholder in AbbVie, Gilead, and Merck and receives grant or research support from Merck. All of the relevant financial relationships listed have been mitigated.